Menopausal Hot Flashes
Menopausal Hot Flashes Market Forecasts to 2030 - Global Analysis By Product (Tablets, Patches, Creams & Gels, Injections and Other Products), Treatment Type, Severity, Application, End User and By Geography
According to Stratistics MRC, the Global Menopausal Hot Flashes Market is accounted for $17.27 billion in 2024 and is expected to reach $24.45 billion by 2030 growing at a CAGR of 7.2% during the forecast period. Menopausal hot flashes are sudden, intense feelings of heat that typically affect women in their late 40s to early 50s, marking the transition into menopause. These flashes can last from a few seconds to several minutes, accompanied by sweating, flushing of the face, and a rapid heartbeat. They are caused by hormonal fluctuations, particularly a decline in estrogen levels, which disrupt the body's temperature regulation.
According to an article published in the Journal of the North American Menopause Society in August 2021, it has been observed that the prevalence of vasomotor menopausal symptoms was high in the United States with 77%.
Market Dynamics:
Driver:
Global aging population
As women age, they are more likely to experience hot flashes, a common symptom of menopause, driving the demand for treatments and therapies to alleviate these symptoms. With a larger demographic entering menopausal age brackets, there's an increased market for pharmaceuticals, hormone therapies, and alternative remedies aimed at alleviating hot flashes and related discomfort. This demographic shift amplifies the focus on menopausal health, spurring innovation and investment in research and development within the menopausal hot flashes market.
Restraint:
Safety concerns
Safety concerns in the menopausal hot flashes market primarily revolve around the use of hormone replacement therapies due to potential risks such as increased likelihood of breast cancer, blood clots, and stroke. Additionally, there are concerns regarding the efficacy and safety of alternative treatments such as herbal supplements. These safety concerns hinder market growth by impacting patient confidence, leading to decreased adoption rates and reluctance among healthcare providers to prescribe certain treatments.
Opportunity:
Mounting modern lifestyles
Mounting modern lifestyles, characterized by stress, erratic sleep patterns, and unhealthy dietary habits, contribute to hormonal imbalances in women, exacerbating menopausal symptoms like hot flashes. Increased prevalence of sedentary lifestyles and environmental factors also play a role. Pharmaceutical companies respond with innovative treatments and therapies to address this growing consumer need. As women seek effective solutions to manage their symptoms and maintain their quality of life, the market for products targeting menopausal hot flashes expands rapidly.
Threat:
Rising availability of alternative therapies
The increasing availability of alternative therapies for menopausal hot flashes, such as herbal supplements, acupuncture, and lifestyle changes, poses a challenge to the growth of traditional pharmaceutical treatments. Additionally, the efficacy and safety of some alternative therapies may not be thoroughly researched or regulated, leading to uncertainties among patients and healthcare providers. This shift reduces demand for conventional medications, impacting market growth.
Covid-19 Impact
The covid-19 pandemic has impacted the menopausal hot flashes market by disrupting healthcare services, delaying diagnosis, and reducing patient visits. Supply chain disruptions have affected the availability of medications and treatments. Economic uncertainties have led to financial constraints among patients, affecting their ability to afford treatments. However, increased telemedicine adoption and virtual consultations have partially mitigated these challenges by providing alternative healthcare access options.
The hormonal treatment segment is expected to be the largest during the forecast period
The hormonal treatment segment is estimated to have a lucrative growth. Hormonal treatments for menopausal hot flashes often involve hormone replacement therapy (HRT), which includes estrogen alone or combined with progesterone. These treatments help regulate hormone levels, alleviating symptoms like hot flashes. HRT can be administered through pills, patches, gels, or creams. It's effective but may carry risks such as blood clots, stroke, or breast cancer, so it's usually recommended for the shortest duration necessary and under medical supervision.
The women on hormone therapy segment is expected to have the highest CAGR during the forecast period
The women on hormone therapy segment is anticipated to witness the highest CAGR growth during the forecast period. Menopausal hot flashes in women on hormone therapy (HT) can be effectively managed with estrogen or a combination of estrogen and progestin. HT helps reduce the frequency and severity of hot flashes by stabilizing hormone levels. However, it may have side effects and is not suitable for everyone. Women considering HT should discuss risks and benefits with their healthcare provider to determine the best course of action for their symptoms.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period. Increasing awareness about menopausal health, coupled with a rising aging population, particularly in countries like Japan and South Korea, is driving market expansion. The adoption of Western lifestyles, including dietary changes and sedentary habits, is contributing to a higher prevalence of menopausal symptoms. Nevertheless, advancements in telemedicine and increasing healthcare infrastructure are gradually addressing these barriers, fostering market development.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period. The region's aging population, combined with a high level of awareness about menopausal symptoms and their management, drives demand for effective treatments. Technological advancements in pharmaceuticals offer innovative solutions, although safety concerns regarding hormone therapy persist. The market in North America remains significant, with a range of treatment options available to cater to the needs of women experiencing menopausal hot flashes.
Key players in the market
Some of the key players profiled in the Menopausal Hot Flashes Market include Pfizer Inc., Allergan PLC, Bayer AG, Novartis AG, GlaxoSmithKline PLC, Johnson & Johnson, Novo Nordisk A/S, Teva Pharmaceutical Industries Limited, Mylan N.V., Amgen Inc., Merck & Co Inc., Perrigo Company, Astellas Pharma Inc., TherapeuticsMD Inc., Hisamitsu Pharmaceutical Corporation and Endo International PLC.
Key Developments:
In May 2023, Astellas Pharma Inc. announced that the U.S. Food and Drug Administration (FDA) has approved VEOZAHTM (fezolinetant) 45 mg once daily for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause1. VEOZAH is the first nonhormonal neurokinin 3 (NK3) receptor antagonist approved to treat VMS due to menopause.
Products Covered:
• Tablets
• Patches
• Creams & Gels
• Injections
• Other Products
Treatment Types Covered:
• Hormonal Treatment
• Non-Hormonal Treatment
• Over-the-Counter (OTC) Products
• Alternative Therapies
Severities Covered:
• Mild
• Moderate
• Severe
Applications Covered:
• Perimenopausal & Postmenopausal Women
• Breast Cancer Patients
• Women on Hormone Therapy
• Other Applications
End Users Covered:
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Menopausal Hot Flashes Market, By Product
5.1 Introduction
5.2 Tablets
5.3 Patches
5.4 Creams & Gels
5.5 Injections
5.6 Other Products
6 Global Menopausal Hot Flashes Market, By Treatment Type
6.1 Introduction
6.2 Hormonal Treatment
6.2.1 Estrogen Replacement Therapy
6.2.2 Progesterone Replacement Therapy
6.2.3 Combination Therapy
6.3 Non-Hormonal Treatment
6.3.1 Antidepressants
6.3.2 Anticonvulsants
6.3.3 Antihypertensives
6.4 Over-the-Counter (OTC) Products
6.4.1 Herbal Supplements
6.4.2 Vitamins & Minerals
6.4.3 Phytoestrogens
6.5 Alternative Therapies
6.5.1 Acupuncture
6.5.2 Yoga & Exercise Programs
6.5.3 Behavioral Therapies
7 Global Menopausal Hot Flashes Market, By Severity
7.1 Introduction
7.2 Mild
7.3 Moderate
7.4 Severe
8 Global Menopausal Hot Flashes Market, By Application
8.1 Introduction
8.2 Perimenopausal & Postmenopausal Women
8.3 Breast Cancer Patients
8.4 Women on Hormone Therapy
8.5 Other Applications
9 Global Menopausal Hot Flashes Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Homecare
9.4 Specialty Clinics
9.5 Other End Users
10 Global Menopausal Hot Flashes Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Pfizer Inc.
12.2 Allergan PLC
12.3 Bayer AG
12.4 Novartis AG
12.5 GlaxoSmithKline PLC
12.6 Johnson & Johnson
12.7 Novo Nordisk A/S
12.8 Teva Pharmaceutical Industries Limited
12.9 Mylan N.V.
12.10 Amgen Inc.
12.11 Merck & Co Inc.
12.12 Perrigo Company
12.13 Astellas Pharma Inc.
12.14 TherapeuticsMD Inc.
12.15 Hisamitsu Pharmaceutical Corporation
12.16 Endo International PLC
List of Tables
1 Global Menopausal Hot Flashes Market Outlook, By Region (2022-2030) ($MN)
2 Global Menopausal Hot Flashes Market Outlook, By Product (2022-2030) ($MN)
3 Global Menopausal Hot Flashes Market Outlook, By Tablets (2022-2030) ($MN)
4 Global Menopausal Hot Flashes Market Outlook, By Patches (2022-2030) ($MN)
5 Global Menopausal Hot Flashes Market Outlook, By Creams & Gels (2022-2030) ($MN)
6 Global Menopausal Hot Flashes Market Outlook, By Injections (2022-2030) ($MN)
7 Global Menopausal Hot Flashes Market Outlook, By Other Products (2022-2030) ($MN)
8 Global Menopausal Hot Flashes Market Outlook, By Treatment Type (2022-2030) ($MN)
9 Global Menopausal Hot Flashes Market Outlook, By Hormonal Treatment (2022-2030) ($MN)
10 Global Menopausal Hot Flashes Market Outlook, By Estrogen Replacement Therapy (2022-2030) ($MN)
11 Global Menopausal Hot Flashes Market Outlook, By Progesterone Replacement Therapy (2022-2030) ($MN)
12 Global Menopausal Hot Flashes Market Outlook, By Combination Therapy (2022-2030) ($MN)
13 Global Menopausal Hot Flashes Market Outlook, By Non-Hormonal Treatment (2022-2030) ($MN)
14 Global Menopausal Hot Flashes Market Outlook, By Antidepressants (2022-2030) ($MN)
15 Global Menopausal Hot Flashes Market Outlook, By Anticonvulsants (2022-2030) ($MN)
16 Global Menopausal Hot Flashes Market Outlook, By Antihypertensives (2022-2030) ($MN)
17 Global Menopausal Hot Flashes Market Outlook, By Over-the-Counter (OTC) Products (2022-2030) ($MN)
18 Global Menopausal Hot Flashes Market Outlook, By Herbal Supplements (2022-2030) ($MN)
19 Global Menopausal Hot Flashes Market Outlook, By Vitamins & Minerals (2022-2030) ($MN)
20 Global Menopausal Hot Flashes Market Outlook, By Phytoestrogens (2022-2030) ($MN)
21 Global Menopausal Hot Flashes Market Outlook, By Alternative Therapies (2022-2030) ($MN)
22 Global Menopausal Hot Flashes Market Outlook, By Acupuncture (2022-2030) ($MN)
23 Global Menopausal Hot Flashes Market Outlook, By Yoga & Exercise Programs (2022-2030) ($MN)
24 Global Menopausal Hot Flashes Market Outlook, By Behavioral Therapies (2022-2030) ($MN)
25 Global Menopausal Hot Flashes Market Outlook, By Mild (2022-2030) ($MN)
26 Global Menopausal Hot Flashes Market Outlook, By Moderate (2022-2030) ($MN)
27 Global Menopausal Hot Flashes Market Outlook, By Severe (2022-2030) ($MN)
28 Global Menopausal Hot Flashes Market Outlook, By Application (2022-2030) ($MN)
29 Global Menopausal Hot Flashes Market Outlook, By Perimenopausal & Postmenopausal Women (2022-2030) ($MN)
30 Global Menopausal Hot Flashes Market Outlook, By Breast Cancer Patients (2022-2030) ($MN)
31 Global Menopausal Hot Flashes Market Outlook, By Women on Hormone Therapy (2022-2030) ($MN)
32 Global Menopausal Hot Flashes Market Outlook, By Other Applications (2022-2030) ($MN)
33 Global Menopausal Hot Flashes Market Outlook, By End User (2022-2030) ($MN)
34 Global Menopausal Hot Flashes Market Outlook, By Hospitals (2022-2030) ($MN)
35 Global Menopausal Hot Flashes Market Outlook, By Homecare (2022-2030) ($MN)
36 Global Menopausal Hot Flashes Market Outlook, By Specialty Clinics (2022-2030) ($MN)
37 Global Menopausal Hot Flashes Market Outlook, By Other End Users (2022-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
